Contents
Current Pharmaceutical Design, Volume 15 - Number 22
The Effects of Antipsychotics on the Brain: What Have We Learnt from Structural Imaging of Schizophrenia? – A Systematic Review
, 15(22): 2535 - 2549R. Smieskova, P. Fusar-Poli, P. Allen, K. Bendfeldt, R. D. Stieglitz, J. Drewe, E. W. Radue, P. K. McGuire, A. Riecher-Rossler and S. J. Borgwardt
DOI: 10.2174/138161209788957456
Mechanisms Underlying Psychosis and Antipsychotic Treatment Response in Schizophrenia: Insights from PET and SPECT Imaging
, 15(22): 2550 - 2559O. D. Howes, A. Egerton, V. Allan, P. McGuire, P. Stokes and S. Kapur
DOI: 10.2174/138161209788957528
Functional Imaging as a Tool to Investigate the Relationship between Genetic Variation and Response to Treatment with Antipsychotics
, 15(22): 2560 - 2572A. Di Giorgio, F. Sambataro and A. Bertolino
DOI: 10.2174/138161209788957483
What do ERPs and ERFs Reveal About the Effect of Antipsychotic Treatment on Cognition in Schizophrenia?
, 15(22): 2573 - 2593M. Korostenskaja and S. Kahkonen
DOI: 10.2174/138161209788957474
Imaging the Neural Effects of Cannabinoids: Current Status and Future Opportunities for Psychopharmacology
, 15(22): 2603 - 2614S. Bhattacharyya, J. A. Crippa, R. Martin-Santos, T. Winton-Brown and P. Fusar-Poli
DOI: 10.2174/138161209788957465
Connecting the Brain and New Drug Targets for Schizophrenia
, 15(22): 2615 - 2631H. C. Whalley, J. D. Steele, P. Mukherjee, L. Romaniuk, A. M. McIntosh, J. Hall and S. M. Lawrie
DOI: 10.2174/138161209788957500
Myelination in Bipolar Patients and the Effects of Mood Stabilizers on Brain Anatomy
, 15(22): 2632 - 2636Paolo Brambilla, Marcella Bellani, Ping-Hong Yeh and Jair C. Soares
DOI: 10.2174/138161209788957519
Neuroimaging and Genetics of Antidepressant Response to Sleep Deprivation: Implications for Drug Development
, 15(22): 2637 - 2649Francesco Benedetti and Enrico Smeraldi
DOI: 10.2174/138161209788957447
Webmaster Contact: info@benthamscience.org